Home
Conditions
Lymphoma, T-Cell

Clinical trial condition

Lymphoma, T-Cell

Explore clinical trials studying Lymphoma, T-Cell. Study availability and eligibility vary by location and protocol.

701 public trials 104 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, T-Cell trial results

Recruiting

Prospective Observational International Registry of Patients With Newly Diagnosed Peripheral T Cell Lymphoma.

NCT03964480

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Stanford University Stanford, California, United States

IRCCS Istituto Tumori "Giovanni Paolo II" Bari, Italy

Palermo_La Maddalena Palermo, Italy

Terni-Santa Maria Terni, Italy

View Trial Details

Recruiting

Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL

NCT06382844

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Instituto de Investigación Biomédica de Salamanca (IBSAL) Salamanca, Spain

View Trial Details

Recruiting

A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies

NCT06914037

Conditions: Cutaneous T-cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCL

NCT06855823

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell Lymphoma

NCT06824883

Conditions: Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma

NCT05958719

Conditions: Epigenetic Repression, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Golidocitinib Plus CHOP in Newly Diagnosed PTCL

NCT06739265

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Recruiting

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

NCT06732492

Conditions: CART Therapy, CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies, Lymphoma, +6 more
Locations: Union Hospital Wuhan, Hubei, China

View Trial Details

Recruiting

A Study of GFH009 Monotherapy in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

NCT05934513

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Sun Yat-sen University Cancer Center Guanzhou, Guangdong, China

View Trial Details

Recruiting

MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy

NCT05333367

Conditions: Cutaneous T-Cell Lymphoma, Graft Rejection, Graft vs Host Disease, +11 more
Locations: Centre Hospitalier Universitaire de Besançon Besançon, France

View Trial Details

Lymphoma, T-Cell

Lymphoma, T-Cell trial results

Related conditions